日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Concurrent trastuzumab deruxtecan-induced interstitial lung disease and COVID-19 in the treatment of advanced breast cancer

曲妥珠单抗德鲁替康治疗晚期乳腺癌并发间质性肺病和 COVID-19

Yasuda, Naoaki; Ikeo, Satoshi; Sokai, Akihiko; Sakai, Yuki; Hayashi, Yasuyuki; Kitano, Sae; Itoi, Naoko; Lee, Tecchuu; Iwata, Toshiyuki; Nishimura, Takashi

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01

HER2阳性早期乳腺癌患者曲妥珠单抗治疗的疗效:JBCRG队列研究01的延长随访

Yamashiro, Hiroyasu; Iwata, Hiroji; Masuda, Norikazu; Yamamoto, Naohito; Nishimura, Reiki; Ohtani, Shoichiro; Sato, Nobuaki; Takahashi, Masato; Kamio, Takako; Yamazaki, Kosuke; Saito, Tsuyoshi; Kato, Makoto; Lee, Tecchuu; Kuroi, Katsumasa; Takano, Toshimi; Yasuno, Shinji; Morita, Satoshi; Ohno, Shinji; Toi, Masakazu

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study

接受新辅助/辅助曲妥珠单抗联合多药化疗治疗的HER2阳性复发性乳腺癌患者再次接受曲妥珠单抗联合细胞毒性化疗的生存结局:一项日本多中心观察性研究

Yamashiro, Hiroyasu; Sawaki, Masataka; Masuda, Norikazu; Okumura, Yasuhiro; Takano, Toshimi; Tokunaga, Eriko; Saito, Tsuyoshi; Sagara, Yasuaki; Yamazaki, Kosuke; Kawaguchi, Yoshihiro; Lee, Tecchuu; Ozaki, Shinji; Yamagami, Kazuhiko; Yamamoto, Naohito; Kuroi, Katsumasa; Suwa, Hirofumi; Ohtani, Shoichiro; Ito, Toshikazu; Yasuno, Shinji; Morita, Satoshi; Ohno, Shinji; Toi, Masakazu

Ectopic gastrointestinal variceal bleeding with portal hypertension

异位胃肠道静脉曲张出血伴门静脉高压

Minowa, Keita; Komatsu, Shuhei; Takashina, Kenichiro; Tanaka, Sachie; Kumano, Tatsuya; Imura, Kenichiro; Shimomura, Katsumi; Ikeda, Jun; Taniguchi, Fumihiro; Ueshima, Yasuo; Lee, Tecchuu; Ikeda, Eito; Otsuji, Eigo; Shioaki, Yasuhiro